M S G Pharma India Private Limited
M S G Pharma India Private Limited is a Private Non-govt company company incorporated in 1998 and based in Delhi, India. M S G Pharma India Private Limited operates in Wholesale Trade (NIC 51109) with authorized capital of ₹5.00 L and paid-up capital of ₹5.00 L. For 2022-23, the company reported revenue of ₹75.15 L and profit after tax of ₹7.67 L. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Explore the complete profile of M S G PHARMA INDIA PRIVATE LIMITED, including financials and company filings, contact details, and much more on Tracxn.
Quick facts
Directors
LockedDirectors, DINs & appointment history for M S G Pharma India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 26 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +14d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for M S G Pharma India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 938986073 | Axis Bank Ltd(Bank) | ₹22.30 Cr | 19 Sep 2019 | Open |
| 847204589 | Axis Bank Ltd(Bank) | ₹19.08 Cr | 04 Jul 2022 | Satisfied |
| 914569000 | Axis Bank Ltd(Bank) | ₹18.15 Cr | 19 Sep 2019 | Satisfied |
| 254866071 | Kotak Mahindra Bank Ltd(Bank) | ₹11.40 Cr | 04 Jul 2022 | Open |
Charge IDs, lenders & amounts for M S G Pharma India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2022-23 | 2021-22 | 2020-21 | 2019-20 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | +80.0% | +0.0% | +5.0% | |
| Profit after Tax2022-23 | +68.0% | +1.0% | +76.0% | |
| Net Worth2022-23 | — | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +0.57% | — | +1.80% | +0.62% | 2.90 | |||
| 2016-17 | +0.95% | +21.37% | — | +1.97% | — | |||
| 2017-18 | +5.92% | +36.75% | +22.51% | +9.87% | 2.28 | |||
| 2019-20 | +9.50% | +7.85% | — | +11.43% | — | |||
| 2020-21 | +10.71% | -34.04% | — | +11.80% | — | |||
| 2021-22 | +10.31% | +31.80% | — | +12.97% | — | |||
| 2022-23 | +10.21% | +11.96% | — | +11.21% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 1,31,53,027 | 78.63% |
| Institutional Investors | 1 | 14,74,956 | 8.82% |
| Public & Others | 44 | 20,99,787 | 12.55% |
Promoter, institutional & public holding for M S G Pharma India Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
170 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.